We are honored to announce that we have been named one of the Top 10 Biotechnology Solution Providers for the second year in a row by CIO Applications.
We are at a point where precision medicine is taking off.The Centers for Medicare & Medicaid Services (CMS) has started to reimburse testing labs for NGS-based tests. This is a game changer for our industry because this means other significant players will follow suit, eventually. If you view this from a clinical lab or hospital’s perspective, there is only one consequence: the number of samples that need to be assessed and clinically evaluated will go up significantly. It is safe to assume, that growth rates will reach the double digits or more. Yet,in the labs, we’re not doubling or tripling the workforce simply because there are not that many people with the necessary training and formal qualifications.
-CIO Applications Interview with Andreas Scherer, Ph.D
The answer to this challenge is automation, and that is where Golden Helix comes in. We cover the whole value chain. Our products make the individual analyst much more efficient,increasing their throughput dramatically. In addition, we positively impact quality, as our software takes on a lot of the tedious legwork and crosschecking.Through all of this, we are supporting the industry in becoming more productive, efficient, and able to deal with this wave of increasing samples.
You can access the entire article featuring an interview with Golden Helix CEO, Andreas Scherer, Ph.D.: https://www.cioapplications.com/magazines/December2018/BioTech/#page=18